The American Journal of Infectious Diseases Publishes Cure For Long COVID-19 Symptoms

–News Direct–

Cure for long COVID-19 reported in the

American Journal of Infectious Diseases

Kansas City, MO, October 25, 2023 (500NewsWire) In a peer reviewed article, Harvard Trained Neurosurgeon Robert M. Beatty M.D. has published an article reporting a cure for long COVID-19. The article is published in the prestigious medical journal THE AMERICAN JOURNAL OF INFECTIOUS DISEASES.

The article is entitled, Long COVID-19 Symptoms Remedied By Anti-Viral Treatment in Neurosurgical Patients

Dr. Beatty reported a safe effective treatment that could help thousands suffering with long COVID-19. The COVID-19 pandemic left many people with long COVID-19 symptoms. Their symptoms are extensive and diverse, with no universal treatment. Dr. Beatty reported case histories of patients with diverse symptoms, each suffering from long COVID-19. The patients symptom resolved or greatly improved upon taking the anti-viral drug acyclovir. Acyclovir is a commonly used and a readily available drug. Acyclovir is inexpensive and considered safe to use.

Dr. Beatty also reported his scientific theory as to why the treatment worked by explaining the pathophysiology of long COVID-19 and its symptoms. This theory is also presented in his published article, Long COVID-19 Symptoms Remedied By Anti-Viral Treatment in Neurosurgical Patients

The purpose of his paper was to present Dr. Beattys results and his scientific theory to the medical world and to the general public. Hopefully it will provide a foundation for much bigger studies. It is hoped the article will provide useful knowledge and be a resource to halt long COVID-19 and its effects.

Dr. Beattys paper concludes with his hope other researchers will contribute to his observation.

This information has been published for the medical worlds information. It also needs to be released to the general public.

Contact Details

Robert M. Beatty M.D.

+1 913-558-1539

Company Website

View source version on


comtex tracking


About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Gio News UK journalist was involved in the writing and production of this article.